A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
Status:
Unknown status
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The aim of our study is to validate the non-invasive model which was constructed by our
previous study for evaluating liver fibrosis or cirrhosis caused by hepatitis B virus in
mainland China and to find a therapeutic regimen to reverse liver fibrosis and cirrhosis.